Abbott Laboratories (ABT) (JOBS) to Stop European Sales of Diet Drug Sold Under the Names Reductil, Reduxade and Zelium in Europe and Meridia in the United States  
1/22/2010 6:45:22 AM

Bookmark and Share

Reuters -- Abbott Laboratories (ABT.N) said on Thursday it will suspend European sales of a weight- loss pill in the face of a recommendation by regulators that heart-related risks made the prescription drug too dangerous.